19.15
0.00
(0.00%)
At close: February 25 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
147,810
147,810
-1,918,804
-2,024,843
-307,688
Investing Cash Flow
-998,662
-998,662
-1,435,185
-2,698,148
-5,184,588
Financing Cash Flow
2,587,257
2,587,257
2,892,082
5,003,361
4,912,121
End Cash Position
2,745,693
2,745,693
1,016,165
1,359,408
1,276,178
Capital Expenditure
-1,383,460
-1,383,460
-1,381,730
-1,847,516
-771,778
Issuance of Capital Stock
2,255,116
2,255,116
2,131,059
3,950,520
4,662,363
Issuance of Debt
1,335,549
1,335,549
1,080,172
1,463,083
372,178
Repayment of Debt
-917,050
-917,050
-365,000
-255,000
-17,000
Free Cash Flow
-1,235,650
-1,235,650
-3,300,534
-3,872,359
-1,079,466
12/31/2020 - 4/30/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
301207.SZ Hualan Biological Vaccine Inc.
18.13
+1.45%
600161.SS TIANTAN BIO
20.10
+1.72%
CSPHF CStone Pharmaceuticals
0.2760
0.00%
SBMFF Sino Biopharmaceutical Limited
0.4240
0.00%
SBHMY Sino Biopharmaceutical Limited
8.06
0.00%
UCBJF UCB SA
192.00
+1.05%
096530.KQ Seegene, Inc.
24,650.00
+1.65%
WXIBF WuXi Biologics (Cayman) Inc.
2.9100
0.00%
CMXHF CSL Limited
160.00
+0.76%
GNMSF Genmab A/S
229.14
0.00%